DRUG · Unmapped registry intervention
Cipatinib
Find medicine records ·
Find other trials using this name
Clinical trial
Study of Cipatinib in Patients With HER2 Positive or Uncertain Advanced Breast Cancer
NCT01301911
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of Cipatinib in Patients With HER2 Positive or Uncertain Advanced Breast Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
CipatinibDRUG
Sponsors & collaborators
Jiangsu HengRui Medicine Co., Ltd.lead sponsor
Chinese Academy of Medical Sciencescollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01301911 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.